Background: Small for gestational age and birth asphyxia are associated with neonatal transient hyperinsulinism (THI). Some newborns with THI showed marked erythroblastosis on admission to our neonatal intensive care unit. Objective: This study was designed to test our hypothesis that fetal erythroblastosis may be a risk factor for developing THI. Methods: The records of all babies admitted to our neonatal intensive care unit within 24 h of birth between January 2010 and May 2014, and who were born after 34 weeks of gestation, were retrospectively reviewed. Hyperinsulinism was diagnosed as hypoglycemia concomitant with high serum insulin in babies requiring >6 mg/kg/min intravenous glucose and THI as hyperinsulinism without maternal diabetes or genetic disorders. The following three possible risk factors for THI were evaluated: (1) birth weight z-score, (2) 1-min Apgar score and (3) absolute nucleated red blood cell (aNRBC) count on admission. Results: Of 705 infants, 8 were diagnosed with THI. Multivariate logistic regression analysis revealed that the aNRBC count was the most significant risk factor for THI. The median aNRBC count was 181/µl (interquartile range 0-538/µl), and 8 of 71 infants (11.3%) having an aNRBC count >1,413/µl (90th percentile in this study) had THI. The aNRBC counts in the 8 cases with THI were significantly higher than those in the 5 cases with hyperinsulinism caused by maternal diabetes or genetic disorders. Conclusions: This study showed that the aNRBC count was strongly associated with subsequent THI. Fetal erythroblastosis, characterized by chronic fetal hypoxia, may be an indicator of perinatal stress sufficient to cause THI.

Keywords:
Hypoglycemia, Insulin, Small for gestational age, Birth asphyxia, Erythroblastosis
1.
Stanley CA: Hypoglycemia in the neonate. Pediatr Endocrinol Rev 2006;4(suppl 1):76-81.
2.
Collins JE, Leonard JV: Hyperinsulinism in asphyxiated and small-for-dates infants with hypoglycaemia. Lancet 1984;2:311-313.
3.
Hoe FM, Thornton PS, Wanner LA, Steinkrauss L, Simmons RA, Stanley CA: Clinical features and insulin regulation in infants with a syndrome of prolonged neonatal hyperinsulinism. J Pediatr 2006;148:207-212.
4.
Axt-Fliedner R, Hendrik HJ, Wrobel M, Fridrich M, Schmidt W: Significance of high and normal neonatal nucleated red blood cell count in small-for-gestational-age newborns. Clin Exp Obstet Gynecol 2002;29:49-53.
5.
Baschat AA, Gungor S, Kush ML, Berg C, Gembruch U, Harman CR: Nucleated red blood cell counts in the first week of life: a critical appraisal of relationships with perinatal outcome in preterm growth-restricted neonates. Am J Obstet Gynecol 2007;197:288. e1-e8.
6.
Christensen RD, Henry E, Andres RL, Bennett ST: Reference ranges for blood concentrations of nucleated red blood cells in neonates. Neonatology 2011;99:289-294.
7.
Barrett CT, Oliver TK Jr: Hypoglycemia and hyperinsulinism in infants with erythroblastosis fetalis. N Engl J Med 1968;278:1260-1262.
8.
Raivio KO, Osterlung K: Hypoglycemia and hyperinsulinemia associated with erythroblastosis fetalis. Pediatrics 1969;43:217-225.
9.
Perrone S, Vezzosi P, Longini M, Marzocchi B, Tanganelli D, Testa M, Santilli T, Buonocore G: Nucleated red blood cell count in term and preterm newborns: reference values at birth. Arch Dis Child Fetal Neonatal Ed 2005;90:F174-F175.
10.
Kwon MJ, Nam MH, Kim SH, Lim CS, Lee CK, Cho Y, Lee KN, Yoon SY: Evaluation of the nucleated red blood cell count in neonates using the Beckman Coulter UniCel DxH 800 analyzer. Int J Lab Hematol 2011;33:620-628.
11.
Minior VK, Shatzkin E, Divon MY: Nucleated red blood cell count in the differentiation of fetuses with pathologic growth restriction from healthy small-for-gestational-age fetuses. Am J Obstet Gynecol 2000;182:1107-1109.
12.
Ghosh B, Mittal S, Kumar S, Dadhwal V: Prediction of perinatal asphyxia with nucleated red blood cells in cord blood of newborns. Int J Gynaecol Obstet 2003;81:267-271.
13.
Christensen RD, Lambert DK, Richards SD: Estimating the nucleated red blood cell ‘emergence time' in neonates. J Perinatol 2014;34:116-119.
14.
Mizumoto H, Uchio H, Yamashita S, Hata D: Transient neonatal hyperinsulinism with adaptation disorders: a report of three cases. J Pediatr Endocrinol Metab 2015;28:337-340.
15.
Heinis M, Simon MT, IIc K, Mazure NM, Pouyssegur J: Oxygen tension regulates pancreatic β-cell differentiation through hypoxia-inducible factor 1α. Diabetes 2010;59:662-669.
16.
Hakim F, Kaitsuka T, Raeed JM, Wei FY, Shiraki N, Akagi T, Yokota T, Kume S, Tomizawa K: High oxygen condition facilitates the differentiation of mouse and human pluripotent stem cells into pancreatic progenitors and insulin-producing cells. J Biol Chem 2014;289:9623-9638.
17.
Meissner T, Wendel U, Burgard P, Schaetzle S, Mayatepek E: Long-term follow-up of 114 patients with congenital hyperinsulinism. Eur J Endocrinol 2003;149:43-51.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.